GGrantIndex
Sort

48,018 grants matching immunotherapy

Modeling the Role of Lymph Node Metastases in Tumor-Mediated Immunosuppression

$1,970,671
Sylvia Katina Plevritis · Stanford University · U54 · FY2016 · CA

Two Compartment Models to Improve Brain Tumor Therapy

$1,969,722
Edward A Neuwelt · Oregon Health & Science University · R01 · FY2009 · CA

UNIVERSITY OF TEXAS MD ANDERSON SPORE IN OVARIAN CANCER

$1,969,594
University Of Texas Md Anderson Can Ctr · P50 · FY2000 · CA

Radiation-induced molecular targets

$1,968,826
Norman Coleman · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Colorado Head and Neck Cancer SPORE

$1,968,453
Antonio Jimeno · University Of Colorado Denver · P50 · FY2021 · CA

Combination immunotherapy with gene modified CD4 and CD8 T cells and stem cells

$1,967,243
Carl H. June · University Of Pennsylvania · U19 · FY2009 · AI

Novel Cord Blood-Derived Cellular Therapies

$1,966,908
Elizabeth J Shpall · University Of Tx Md Anderson Can Ctr · P01 · FY2018 · CA

Immunotherapy for Ocular Surface Diseases

$1,965,886
Sandeep Jain · University Of Illinois At Chicago · R24 · FY2022 · EY

Pathogenesis and countermeasures of poxviruses and hemorrhagic fever viruses

$1,965,696
Peter Jahrling · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI

CIP Microbiome and Genetics Core

$1,964,469
Colm Ohuigin · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA

Center for Immunotherapies to Zoonotic Diseases

$1,963,653
Mark T Quinn · Montana State University - Bozeman · P20 · FY2008 · RR

ADULT AIDS CLINICAL TRIALS UNIT (AACTU)

$1,963,534
University Of Rochester · U01 · FY2003 · AI

Children's Oncology Group

$1,962,900
Todd A Alonzo · University Of Southern California · U10 · FY2025 · CA

Preclinical drug development in pancreatic cancer

$1,962,634
Udo Rudloff · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Immunological Analysis of Brain Cancer

$1,962,200
Masaki Terabe · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Enhancing T Cell Therapy of Cancer

$1,961,712
Helen E Heslop · Baylor College Of Medicine · P01 · FY2009 · CA

Multidimensional development of high-affinity anti-glycan antibodies to fight deadly bacterial infections

$1,961,391
Luc Teyton · Scripps Research Institute, The · P01 · FY2025 · AI

An Orbitrap Astral Mass Spectrometer for Elevating Proteomics Sensitivity at Rutgers Biomedical and Health Sciences Newark Campus

$1,960,930
Hong Li · Rutgers Biomedical And Health Sciences · S10 · FY2025 · OD

MEMORIAL SLOAN-KETTERING CANCER GENE THERAPY PROGRAM

$1,959,185
Sloan-Kettering Institute For Cancer Res · P01 · FY2003 · CA

SPORE In Prostate Cancer

$1,957,034
William George Nelson · Johns Hopkins University · P50 · FY2012 · CA

Anti-HIV Gene Therapy: Defend and Attack

$1,956,462
Irvin S.y. Chen · University Of California Los Angeles · U19 · FY2018 · AI

SPORE IN OVARIAN CANCER

$1,956,437
University Of Alabama At Birmingham · P50 · FY2002 · CA

Miami Center for AIDS Research

$1,955,401
Savita Pahwa · University Of Miami School Of Medicine · P30 · FY2022 · AI

Radiopharmaceutical Imaging and Therapy of Cancer

$1,954,858
Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Parkinson's Disease and Dementia

$1,953,061
John Q. Trojanowski · University Of Pennsylvania · P50 · FY2014 · NS